Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBJ.3NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
XBJ.3NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
XBJ.3NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBJ.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBJ.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBJ.3NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XBJ.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBJ.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBJ.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBJ.3NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XBJ.3NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
XBJ.3NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
XBJ.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBJ.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBJ.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBJ.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
EP.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
EP.2NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
EP.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
EP.2NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
EP.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
EP.2NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
EP.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EP.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EP.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
EP.2NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
EP.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
EP.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EP.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
EP.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
EP.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EP.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EP.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
EP.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
EP.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
EP.2NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
EP.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EP.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EP.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EP.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
BA.4.1.5NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
BA.4.1.5NCN-CDC-NCAGACATTTTGCTCTCAAGCTG2245.452897928958R-23140.2China
BA.4.1.5NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BA.4.1.5NNIH-TH_NCCCCACTGCGTTCTCCATT1957.892837628358R-3370.08Thailand
BA.4.1.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.4.1.5NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-25148.4US
BA.4.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.1.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.4.1.5NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BA.4.1.5NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-23779.6US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used